BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7574352)

  • 41. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
    Cocilovo C; Boolbol SK; Valdes E; Feldman S
    Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation.
    Fortin A; Dagnault A; Blondeau L; Vu TT; Larochelle M
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):33-9. PubMed ID: 16542789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized controlled trial of fibrin sealant to reduce postoperative drainage following elective lymph node dissection.
    Swan MC; Oliver DW; Cassell OC; Coleman DJ; Williams N; Morritt DG; Giele HP
    Br J Surg; 2011 Jul; 98(7):918-24. PubMed ID: 21456091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrin sealant decreases postoperative drainage in immediate breast reconstruction by deep inferior epigastric perforator flap after mastectomy with axillary dissection.
    Hivelin M; Heusse JL; Matar N; Lepage C; Lantieri L
    Microsurgery; 2011 Jan; 31(1):18-25. PubMed ID: 20878653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer.
    Jain PK; Sowdi R; Anderson AD; MacFie J
    Br J Surg; 2004 Jan; 91(1):54-60. PubMed ID: 14716794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
    Yu J; Li G; Li J; Wang Y
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
    Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
    Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mastectomy without drain at pectoral area: a randomized controlled trial.
    Puttawibul P; Sangthong B; Maipang T; Sampao S; Uttamakul P; Apakupakul N
    J Med Assoc Thai; 2003 Apr; 86(4):325-31. PubMed ID: 12757076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Control of aerostasis in pulmonary metastasectomy by precision resection. Standard technique versus fibrin glue modification].
    Massone PP; Lequaglie C; Magnani B; Conti B; Cataldo I
    Chir Ital; 2002; 54(4):447-53. PubMed ID: 12239753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mini-invasive technique for axillary lymphadenectomy in early breast cancer: a study of 15 patients.
    Cangiotti L; Poiatti R; Taglietti L; Re P; Carrara B
    J Exp Clin Cancer Res; 1999 Sep; 18(3):295-8. PubMed ID: 10606172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sentinel lymphadenectomy for breast cancer in a community managed care setting.
    Guenther JM; Krishnamoorthy M; Tan LR
    Cancer J Sci Am; 1997; 3(6):336-40. PubMed ID: 9403045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
    Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J
    Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Axillary lymphadenectomy for breast cancer and fibrin glue.
    Ruggiero R; Docimo G; Gubitosi A; Conzo G; Tolone S; Gili S; Bosco A; Docimo L
    Ann Ital Chir; 2014; 85(1):88-92. PubMed ID: 23080086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial.
    Gilly FN; François Y; Sayag-Beaujard AC; Glehen O; Brachet A; Vignal J
    Eur Surg Res; 1998; 30(6):439-43. PubMed ID: 9838238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial.
    Moore M; Burak WE; Nelson E; Kearney T; Simmons R; Mayers L; Spotnitz WD
    J Am Coll Surg; 2001 May; 192(5):591-9. PubMed ID: 11333096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study.
    El Nakeeb A
    Breast J; 2009; 15(6):671-2. PubMed ID: 19558542
    [No Abstract]   [Full Text] [Related]  

  • 59. [Radical prostatectomy and biologic glue].
    Lobel B; Ordonez O; Olivo JF; Cipolla B; Milon D; Leveque JM; Guille F
    Prog Urol; 1991 Jun; 1(3):440-4. PubMed ID: 1844718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of seroma following axillary lymph node dissection or radical mastectomy; ineffectiveness of fibrin glue sealing technique.
    Jonk A; van Dongen JA; Kroon BB
    Neth J Surg; 1987 Aug; 39(4):135. PubMed ID: 2446206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.